1st Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$4,650,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill Trans-Atlantic trade & Investment Partnership Canada IP/Trade Issues South Africa IP Issues China IP Indonesia IP Thailand IP Korea Pricing Issues United Nations Health Panel G7/G20 APEC OECD Australia Market - Size Damages WTO "Zero for Zero" Pharmaceutical Agreement NAFTA

LobbyistCovered position, as disclosed
DOUGLAS REID GOUDIE —

Contacted: SENATE; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Natl Economic Council (NEC); State, Dept of (DOS); Executive Office of the President (EOP); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); White House Office; Treasury, Dept of; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Creates Act Patent Settlements Transferable exclusivity

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ROBERT JONES New —

Contacted: Executive Office of the President (EOP); State, Dept of (DOS); U.S. Trade Representative (USTR); White House Office; Commerce, Dept of (DOC); Treasury, Dept of; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of the Vice President of the United States; SENATE; Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Health Issues HCR

Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Natl Economic Council (NEC); Food & Drug Administration (FDA); SENATE; Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; White House Office; Executive Office of the President (EOP); Treasury, Dept of

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Biosimilar pass-through

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Natl Economic Council (NEC); Patent & Trademark Office (PTO); SENATE; White House Office; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); State, Dept of (DOS); Treasury, Dept of

Budget/Appropriations BUD

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Natl Security Council (NSC); Executive Office of the President (EOP); Natl Economic Council (NEC); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Food & Drug Administration (FDA); Treasury, Dept of; White House Office; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Alcohol and Drug Abuse ALC

Prescription Drug Abuse

LobbyistCovered position, as disclosed
ANGELA WALKER RIEMER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Patent & Trademark Office (PTO); White House Office; State, Dept of (DOS); Treasury, Dept of; Office of the Vice President of the United States; Food & Drug Administration (FDA); Natl Economic Council (NEC)

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform

LobbyistCovered position, as disclosed
CAROLINE MOODY SCHELLHAS —

Contacted: State, Dept of (DOS); White House Office; Patent & Trademark Office (PTO); Natl Security Council (NSC); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC); Executive Office of the President (EOP); Office of the Vice President of the United States; Treasury, Dept of; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.